LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Prilenia Therapeutics B.V.
Headquarters:
Naarden, Netherlands
Website:
https://www.prilenia.com
Year Founded:
2018
Status:
Private
BioCentury
|
Sep 19, 2024
Management Tracks
EMA names Sepodes CHMP chair, Bell leaving Valo as CEO, and more
Plus: Autolus hires Matthias Will as CDO, and updates from HotSpot, Prilenia, Frazier, BIA and BioCentriq
Read More
BioCentury
|
May 30, 2024
Finance
Venture Report: Canadian VC Amplitude closes new fund; CinRx’s series C
Plus: Adcendo’s series A is again Denmark’s largest; VCs and foundations back Lucy
Read More
BioCentury
|
Apr 4, 2024
Management Tracks
Upstream names new CEO, CFO and COO
Plus: Acadia hires Elizabeth Thompson as head of R&D, and updates from Insitro, Fractyl, Adarx and more
Read More
BioCentury
|
Feb 24, 2023
Regulation
Feb. 23 Quick Takes: FDA approves Sanofi’s once-weekly hemophilia A therapy
Plus: CMS stays the course on Alzheimer's NCD and updates from Blueprint, Apellis, AZ, Nektar, Keymed, Prilenia and more
Read More
BioCentury
|
Nov 2, 2022
Emerging Company Profile
ProJenX: protecting neurons to treat ALS
Project ALS and Medical Excellence-backed company hopes to take same regulatory path forged by Amylyx
Read More
BioCentury
|
Sep 30, 2022
Management Tracks
Sullivan becomes CBO at Prilenia
Plus new CMO at Cellectis, and updates from Lyell, Adrestia, Mursla and more
Read More
BioCentury
|
Apr 13, 2022
Product Development
April 12 Quick Takes: FDA lifts clinical hold on magrolimab studies
Plus: Setback for Myovant at FDA and updates from Takeda, Ocugen, Prilenia, AbbVie and more
Read More
BioCentury
|
Apr 1, 2022
Management Tracks
Morgan Stanley’s Christine Ha becomes CFO at Ventus
Plus new CEO at Zealand Pharma, updates from Nuvalent, Pathalys and more
Read More
BioCentury
|
Jan 21, 2022
Data Byte
State of the Huntington’s disease pipeline
Setbacks for HTT-targeting programs have put alternative therapeutic approaches out in front
Read More
BioCentury
|
Nov 4, 2021
Product Development
Nov. 3 Quick Takes: Flagship, CF Foundation forming start-up
Plus Antios raises, Novo Nordisk misses, GRObio, Prilenia and more
Read More
Items per page:
10
1 - 10 of 13
Help Center
Username
Request a Demo
Request Training
Ask a Question
Elevio by Dixa
Help